Recursion (Nasdaq: RXRX), a leading clinical-stage TechBio company decoding biology to radically improve lives, today ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

In other recent news, Recursion Pharmaceuticals reported its fourth-quarter 2025 earnings, delivering results that surpassed expectations. The company posted an earnings per share (EPS) of -$0.21, ...

Nvidia's recent $700 million acquisition of Run:ai enhances GPU access and infrastructure flexibility. The acquisition of OctoAI for $250 million bolsters Nvidia's generative AI tools portfolio.

We may earn commission from links on this page, but we only recommend products we love. Promise. ️ P.S., This is new, up-to-date info, bb. We updated this article in May 2023 to add new top-rated ...

Heart disease in kids can be present at birth or develop later from illness. Congenital heart disease affects about 1 in 100 babies born each year. Atherosclerosis may start in childhood, even without ...

Westchester County has always been home to loads of fun things to do. Whether you’re looking for an entertaining weeknight activity or something to do once your day off rolls around, we’ve got your ...

Recessions often bring lower stock prices, which provide a buying opportunity for long-term investors. Invest regularly during recessions using dollar-cost averaging to minimize the risk and enhance ...

Somer G. Anderson is CPA, doctor of accounting, and an accounting and finance professor who has been working in the accounting and finance industries for more than 20 years. Her expertise covers a ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...